Erlotinib Completed Phase 1 Trials for Neoplasms Treatment

CompletedTreatment1 IdentifierTitleDrugs
NCT00207077Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors
NCT01482377A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin